Processa Pharmaceuticals Inc (PCSA)
1.06
-0.01
(-0.93%)
USD |
NASDAQ |
Nov 14, 16:00
1.06
0.00 (0.00%)
After-Hours: 20:00
Processa Pharmaceuticals Total Assets (Quarterly): 7.601M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 7.601M |
| March 31, 2024 | 9.945M |
| December 31, 2023 | 5.787M |
| September 30, 2023 | 8.083M |
| June 30, 2023 | 10.09M |
| March 31, 2023 | 12.43M |
| December 31, 2022 | 8.620M |
| September 30, 2022 | 18.60M |
| June 30, 2022 | 21.66M |
| March 31, 2022 | 24.30M |
| December 31, 2021 | 26.46M |
| September 30, 2021 | 29.03M |
| June 30, 2021 | 31.14M |
| March 31, 2021 | 33.34M |
| December 31, 2020 | 25.21M |
| September 30, 2020 | 9.589M |
| June 30, 2020 | 10.01M |
| March 31, 2020 | 10.01M |
| December 31, 2019 | 10.88M |
| September 30, 2019 | 10.82M |
| June 30, 2019 | 11.31M |
| March 31, 2019 | 12.08M |
| December 31, 2018 | 12.48M |
| September 30, 2018 | 13.46M |
| Date | Value |
|---|---|
| June 30, 2018 | 14.44M |
| March 31, 2018 | 12.89M |
| December 31, 2017 | 2.983M |
| September 30, 2017 | 0.0803M |
| June 30, 2017 | 0.0019M |
| March 31, 2017 | 0.0016M |
| December 31, 2016 | 0.0032M |
| September 30, 2016 | 0.0352M |
| June 30, 2016 | 0.0435M |
| March 31, 2016 | 0.0473M |
| December 31, 2015 | 0.1043M |
| September 30, 2015 | 0.4981M |
| June 30, 2015 | 0.8777M |
| March 31, 2015 | 2.543M |
| December 31, 2014 | 2.546M |
| September 30, 2014 | 2.667M |
| June 30, 2014 | 2.785M |
| March 31, 2014 | 2.908M |
| December 31, 2013 | 2.938M |
| September 30, 2013 | 3.843M |
| June 30, 2013 | 3.467M |
| March 31, 2013 | 3.185M |
| December 31, 2012 | 3.884M |
| September 30, 2012 | 4.352M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
5.787M
Minimum
Dec 2023
33.34M
Maximum
Mar 2021
16.46M
Average
10.88M
Median
Dec 2019
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 3.925M |
| Palatin Technologies Inc | 10.74M |
| iBio Inc | 28.73M |
| Theriva Biologics Inc | 42.39M |
| Oragenics Inc | 2.710M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.577M |
| Shareholders Equity (Quarterly) | 6.024M |